These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Articular chondroprotection]. Borrachero del Campo J An R Acad Nac Med (Madr); 1987; 104(4):467-80. PubMed ID: 3328523 [No Abstract] [Full Text] [Related]
24. Introduction. New directions in anti-inflammatory therapy and pain management. Hochberg MC Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):1-3. PubMed ID: 12528068 [No Abstract] [Full Text] [Related]
25. The potential role of nitric oxide in cardiovascular safety when treating osteoarthritis in patients with hypertension. Introduction. White WB Am J Med; 2009 May; 122(5 Suppl):S1-2. PubMed ID: 19393820 [No Abstract] [Full Text] [Related]
26. Carprofen simultaneously reduces progression of morphological changes in cartilage and subchondral bone in experimental dog osteoarthritis. Pelletier JP; Lajeunesse D; Jovanovic DV; Lascau-Coman V; Jolicoeur FC; Hilal G; Fernandes JC; Martel-Pelletier J J Rheumatol; 2000 Dec; 27(12):2893-902. PubMed ID: 11128682 [TBL] [Abstract][Full Text] [Related]
27. Novel drug treatment strategies for osteoarthritis. Creamer P; Dieppe PA J Rheumatol; 1993 Sep; 20(9):1461-4. PubMed ID: 8164198 [No Abstract] [Full Text] [Related]
28. Differential anti-inflammatory and chondroprotective effects of simulated digests of indomethacin and an herbal composite (Mobility) in a cartilage explant model of articular inflammation. Pearson W; Orth MW; Lindinger MI J Vet Pharmacol Ther; 2007 Dec; 30(6):523-33. PubMed ID: 17991220 [TBL] [Abstract][Full Text] [Related]
30. Celecoxib has a positive effect on the overall metabolism of hyaluronan and proteoglycans in human osteoarthritic cartilage. El Hajjaji H; Marcelis A; Devogelaer JP; Manicourt DH J Rheumatol; 2003 Nov; 30(11):2444-51. PubMed ID: 14677191 [TBL] [Abstract][Full Text] [Related]
31. The potential role of nitric oxide in cardiovascular safety when treating patients with osteoarthritis and hypertension: a moderated panel discussion. White WB; Pepine CJ; Weber MA Am J Med; 2009 May; 122(5 Suppl):S23-5. PubMed ID: 19393823 [No Abstract] [Full Text] [Related]
32. [Drug therapy and prevention of arthrosis]. Miehlke K Internist (Berl); 1989 Oct; 30(10):643-5. PubMed ID: 2684896 [No Abstract] [Full Text] [Related]
33. The use and safety profile of non-steroidal antiinflammatory drugs among Turkish patients with osteoarthritis. Yilmaz H; Gürel S; Ozdemir O Turk J Gastroenterol; 2005 Sep; 16(3):138-42. PubMed ID: 16245223 [TBL] [Abstract][Full Text] [Related]
38. Will we be able to repair osteoarthritic joints? New drugs and surgical techniques for cartilage problems. Almekinders LC N C Med J; 1999; 60(1):46-8. PubMed ID: 9951289 [No Abstract] [Full Text] [Related]
39. Does oral glucosamine prevent the loss of proteoglycans in a rabbit model of osteoarthritis? Comment on the article by Tiraloche et al. Lammi M Arthritis Rheum; 2005 Nov; 52(11):3680; author reply 3680-81. PubMed ID: 16258912 [No Abstract] [Full Text] [Related]
40. Current nonsteroidal anti-inflammatory drug applications for rheumatic diseases. Kantor TG Prim Care; 1993 Dec; 20(4):955-63. PubMed ID: 8310091 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]